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Abstract p38, which has been suggested to be a sca¡old pro-
tein for the assembly of a macromolecular tRNA synthetase
complex, contains a leucine zipper-like motif. To understand
the importance of the leucine zipper-like motif of p38
(p38LZ) in macromolecular assembly, the p38LZ solution struc-
ture was investigated by circular dichroism and nuclear mag-
netic resonance spectroscopy. The solution structure of p38LZ
showed an amphipathic K-helical structure and characteristics
similar to a coiled-coil motif. The protein^protein interaction
mediated by p38LZ was examined by an in vitro binding assay.
The p43 protein, another non-synthetase component of the com-
plex, could bind to p38LZ via its N-terminal domain, which is
also predicted to have a potential coiled-coil motif. Thus, we
propose that the p38^p43 complex would be formed by coiled-
coil interactions, and the formation of the binary complex would
facilitate the macromolecular assembly of aminoacyl-tRNA syn-
thetases.
) 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Aminoacyl-tRNA synthetase (ARS) catalyzes the attach-
ment of an amino acid to its cognate tRNA. ARSs share a
highly conserved catalytic domain from bacteria to mammals
in the respective synthetases. However, the higher eukaryotic
synthetases exhibit distinctive features. Unique hydrophobic
peptide appendices are present in the mammalian ARSs, but
not in the prokaryotic synthetases [1^5]. Eight synthetase
polypeptides with nine ARS functions are present in the mul-
ti-ARS complex, which consists of DRS, the bifunctional
EPRS, IRS, KRS, LRS, MRS, QRS, and RRS [6^10]. In
addition, three non-synthetase components, with molecular
masses of 18, 38, and 43 kDa (p18, p38, and p43, respec-
tively), were also isolated from the complex [11^13]. Because
of their hydrophobic nature, the unique peptide appendices
from the eight synthetase polypeptides were suggested to
form the interface for the protein^protein interactions [7^9].
To understand the structural organization and the interac-
tions between the synthetase components of the complex, bio-
chemical and genetic approaches have been employed. The
overall structural organization of the complex was revealed
to have an elongated U-shape by electron microscopy
[10,14]. The protein^protein interactions between the synthe-
tase components of the complex were determined by chemical
crosslinking methods [15,16] or by genetic approaches [13].
The non-synthetase components of the macromolecular
ARS complex have been attracting attention recently. One
of the non-synthetase components, p38, was suggested to be
a sca¡old of macromolecular assembly [13,17,18]. The p38
protein shares the putative leucine zipper motif [13], and has
been proposed to interact with several components of the
complex [13,17]. DRS and KRS were each found to bind
tightly to p38, while the binding of RRS or QRS to p38
was much weaker [17]. Additionally, p38 is known to be es-
sential for the assembly and the stability of the macromolec-
ular ARS complex in vivo, and deletion analyses of p38 have
mapped the organization of the component proteins within
the complex [18]. Another non-synthetase component, p43,
also plays a role in the macromolecular assembly. The p43
protein is located in the middle of the complex [19], and has
also been found to bind to QRS and RRS [17,20]. The sub-
complex containing p38, p43, RRS, and QRS was reconsti-
tuted in vitro, and it has been proposed that the assembly of
the sub-complex proceeds through the binary complex p38^
p43, followed by association with RRS and ¢nally with QRS
[17].
In this work, to gain insight into the formation of the multi-
ARS complex, we focused on the structure and binding spec-
i¢city of the leucine zipper-like motif of p38 (p38LZ). The
structural characterization of p38LZ was accomplished by
circular dichroism (CD) and nuclear magnetic resonance
(NMR) spectroscopy. The solution structure of the putative
leucine zipper motif of p38 was determined, and the binding
of p38LZ to other components of the complex was examined
in vitro. These results show that the leucine zipper motif of
p38 is su⁄cient to bind to the N-terminal domain of p43, and
the association of p38 with p43 is mediated by coiled-coil
interactions.
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2. Materials and methods
2.1. Peptide synthesis
The synthetic peptide þH3N-SLQALESRQDDILKRLYEL-
KAAVDGLSKMI-COO3, p38LZ, corresponding to residues 51^80
of human p38, was purchased from Chiron, Australia. The synthetic
peptide was puri¢ed by reverse-phase high performance liquid chro-
matography. The molecular weight of p38LZ, 3405.4 Da, was identi-
¢ed by ion spray mass spectroscopy and was consistent with the
theoretical molecular weight of the peptide, 3405.5 Da.
2.2. CD experiments
CD spectra were recorded on a Jasco J-715 CD spectropolarimeter,
at 25‡C in 2-mm cells from 250 to 190 nm with a scan speed of 20 nm/
min, using 50 WM p38LZ. The CD experiments were performed in
water, or in 30% or 50% 2,2,2-tri£uoroethanol (TFE)/water solutions
at pH 4, to inspect the conformation of p38LZ in an aqueous solution
or in hydrophobic environments. All spectra were measured three
times, and after averaging, the solvent (water or TFE/water solution)
signal was subtracted. The degrees of the signal were converted to
mean residue molar ellipticity [a] (deg cm2/dmol).
2.3. NMR experiments
NMR spectra were obtained on Bruker DRX 500 and 600 MHz
spectrometers at 30‡C using 3 mM p38LZ. The spectra showed over-
lapped or degenerated signals in an aqueous bu¡er solution, at pH 6.5
(data not shown). However, the increase of the TFE-d3 concentration
and the decrease of the pH of the sample to 4.0 eliminated the overlap
of the peaks and a narrower line width was acquired. Thus, all NMR
measurements for structural calculations were performed in TFE-d3/
water (1:1), pH 4.0, with a peptide concentration of 3 mM. Two-
dimensional nuclear Overhauser e¡ect spectroscopy (2D-NOESY)
(mixing times of 120 and 200 ms), total correlation spectroscopy
(TOCSY) (mixing times of 40 and 60 ms), and double quantum ¢l-
tered correlation spectroscopy (DQF-COSY) spectra were acquired
using presaturation of the H2O resonance by continuous irradiation
with a time domain of 2048 (F2)U512 (F1). The sweep widths in both
dimensions were 6009.6 Hz for the Bruker DRX 600 spectrometer.
The data were processed using NMRPipe [21] and were analyzed
using NMRView [22]. The spin systems were identi¢ed from the
TOCSY and DQF-COSY spectra, and the sequence assignment was
unambiguously accomplished using the NOESY spectra (120 ms and
200 ms) by the conventional method [23].
2.4. Structural calculation
Distance restraints were obtained from the NOESY spectrum with
a 200 ms mixing time. The volume of the unambiguously assigned
NOE cross-peaks was converted to the upper bound distance re-
straints of 3.0, 4.0, and 5.0 AS (strong, medium, and weak, respec-
tively) and the lower bound distance restraints were taken as the
sum of the van der Waals radii of 1.8 AS . As no stereospeci¢c assign-
ment could be made for the methyl and methylene protons, pseudoa-
tom corrections were applied [23]. The P angles were constrained to
365U 35‡ for the backbone amides, with 3JHNHK6 6 Hz from the
DQF-COSY experiments. Hydrogen bond restraints were incorpo-
rated on the basis of the slowly exchanging amide protons and the
characteristic NOE pattern of an K-helix. A total of 303 distance
restraints, including 18 hydrogen bond restraints and 15 dihedral an-
gle restraints, were incorporated into the structural calculation using
the simulated annealing and energy minimization protocols in the
program X-PLOR 3.581 [24].
2.5. In vitro binding assay
The plasmids harboring the full-length, the N-terminal domain
(1^147) and the C-terminal domain (148^312) of p43, and the
N-terminal appendices of RRS and QRS were prepared as described
previously [25]. The corresponding proteins, p43, p43-N, p43-C, RRS-
N172, and QRS-N1236, respectively, were expressed as 6-His-tagged
proteins to facilitate their puri¢cation and manipulation.
The proteins were puri¢ed with Chelating Sepharose (Pharmacia,
Uppsala, Sweden), and were dialyzed against binding bu¡er (20 mM
sodium phosphate dibasic, 500 mM NaCl, pH 7.2). Aliquots of the
proteins were mixed with the Chelating Sepharose beads. After incu-
bation at 30‡C for 30 min, aliquots of p38LZ were added to the
protein-bound Chelating Sepharose beads. The concentrations of the
proteins were about 25 WM and that of p38LZ was about 50 WM. The
mixtures were incubated for 30 min at 37‡C and then centrifuged. The
supernatants were discarded and the beads were washed three times
with binding bu¡er. The proteins were eluted from the beads with
binding bu¡er containing 500 mM imidazole. The eluted proteins
were subjected to Tris-Tricine sodium dodecyl sulfate^polyacrylamide
gel electrophoresis (SDS^PAGE), which achieves enhanced resolution
for the smaller proteins or peptides [26]. The protein-bound p38LZ
was detected by Coomassie blue staining.
3. Results and discussion
3.1. Sequence comparison of p38LZ with the leucine zipper
motif of the yeast transcription factor, GCN4
A putative leucine zipper motif is thought to be located
between residues L55 and I80 of the p38 protein [13]. In
this experiment, we selected the peptide sequence between
S51 and I80 of p38. Fig. 1A shows the schematic structure
and the sequence of the leucine zipper-like motif of p38. The
peptide sequence between S51 and I80 of p38 was compared
with that of the leucine zipper dimerization domain from the
yeast transcription factor, GCN4 (GCN4LZ) [27]. The com-
parison of the two sequences revealed high sequence similar-
ity. The hydrophobic residues were located at the a and d
positions in the respective heptad repeats, and even in the
remaining regions, moderate sequence homology existed be-
tween the two peptide motifs. As shown in Fig. 1B, the helical
wheel diagrams of p38LZ and GCN4LZ displayed a similar
distribution of hydrophobic residues, suggesting the presence
of a leucine zipper motif in p38.
3.2. CD spectra of p38LZ
The structural properties of p38LZ were characterized by
CD spectroscopy. In aqueous, 30% and 50% TFE/water solu-
tions, the CD spectra of p38LZ displayed minima near 208
and 222 nm, suggesting that p38LZ adopts an K-helical con-
formation (Fig. 2). It should be noted that p38LZ has an
K-helical structure, even in an aqueous solution. Synthetic
peptides preferably adopt random coil structures in an aque-
ous solution, and their structural transition from coil to helix
occurs in TFE/water mixtures [28,29]. However, in our experi-
ments, p38LZ in the aqueous bu¡er showed a typical K-helical
structure, which suggests that the helical structure of p38LZ
in the hydrophobic environment was not induced by the ad-
dition of TFE. The increase in the CD intensity upon the
addition of TFE suggests that the helical content of p38LZ
Table 1
Structural statistics for the ensemble of 20 structures calculated for
p38LZ
X-PLOR energies (kcal/mol)
Etotal 32.6 U 0.5
Ebond 0.44U0.03
Eangles 26.2 U 0.2
Eimpropers 4.4U 0.06
Evdw 0.94U0.38
ENOE 0.59U0.14
Rmsd from idealized geometry
bonds (AS ) 0.001U0.000
bond angles (‡) 0.44U0.002
improper torsions (‡) 0.35U0.003
Rmsd from experimental restraints
distances (AS ) 0.006U0.001
Rmsd from the mean structure for the backbone/all atoms (AS )
helical region (L55^L76) 0.51/1.23
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is increased. The isodichroic point at 203 nm indicates that the
structures of p38LZ under the three di¡erent solution condi-
tions are similar to each other. Thus, it is likely that the
structure of the synthetic peptide, p38LZ, re£ects the intact
structure of this motif in the native p38 protein, and that the
putative leucine zipper motif of p38 would intrinsically adopt
an K-helical conformation.
3.3. Sequence assignments and secondary structure of p38LZ
The NMR spectrum for p38LZ in an aqueous solution at
pH 6.5 showed broad line widths and overlapping of the sig-
nals. The broadened line width seems to have originated from
the abnormal aggregation of p38LZ, due to its high concen-
tration for the NMR measurements (3 mM p38LZ). The ul-
tracentrifugation experiments to assess the oligomeric state of
p38LZ at neutral pH revealed that no dimerization or oligo-
merization of the peptide had occurred (data not shown). In
the 50% TFE solution, we obtained a well-dispersed and non-
overlapped NMR spectrum. Since p38LZ was proved to have
similar structures in the aqueous and TFE/water solutions, we
performed all the NMR experiments in the 50% TFE/water
solution, at pH 4.0.
Sequence assignments were accomplished from L52 to I80
of p38LZ, from the NOESY spectra. The sequential NOE
connectivities are shown in Fig. 3. The presence of the
HNðiÞ-HNðiþ1Þ, HKðiÞ-HNðiþ1Þ, HKðiÞ-HNðiþ3Þ, HKðiÞ-HLðiþ3Þ,
and HKðiÞ-HNðiþ4Þ NOEs suggests that p38LZ is fully K-heli-
cal. Five NOEs between HKðiÞ and HNðiþ2Þ, which often in-
dicate the presence of 310 helices, were found at the N-termi-
nus and in the middle of p38LZ. However, the weak HKðiÞ-
HNðiþ2Þ NOEs are usually found in an K-helix with an average
distance of 4.4 AS , as compared to that of a 310 helix, 3.8 AS
[23]. Additionally, the helical structure of p38LZ was not
broken before and after the regions showing the HKðiÞ-
HNðiþ2Þ NOEs, since HKðiÞ-HNðiþ4Þ NOEs, which should not
be found in the 310 helix [23], appeared consecutively from
A54 to K78. Therefore, the authors excluded the possibility of
the existence of 310 helices in p38LZ, and concluded that
p38LZ adopts a fully K-helical conformation. The measured
coupling constant values, 3JHNHK, from the DQF-COSY spec-
trum also support the existence of an K-helix. Furthermore, in
the central region of the peptide, the amide protons were
slowly exchanged, suggesting that hydrogen bonds are formed
and stabilize the helical conformation. The NOE-based sec-
ondary structure of p38LZ was consistent with the results of
the CD measurement.
3.4. Three-dimensional structure of p38LZ
The three-dimensional structure of p38LZ is shown in Fig.
4, and the structural statistics are shown in Table 1. The
p38LZ structure is composed of one well-de¢ned K-helix,
spanning the residues from L52 to L76. The N-terminal cap-
ping of the helix was inferred, from the HKðiÞ-HNðiþ2Þ NOE
between L52 and A54, to stabilize the helical conformation of
  
Fig. 2. CD spectra of p38LZ in water (open circles), in 30% (¢lled
circles), and in the 50% TFE/water (open rectangles) solution, at
pH 4.0. p38LZ displays an K-helical conformation in the aqueous
solution. The addition of TFE increased the intensity of the CD sig-
nal and strengthened the stability of the helical p38LZ.
Fig. 1. Sequence comparison of p38LZ with the leucine zipper motif of the yeast transcription factor, GCN4. A: The primary structure of the
leucine zipper motif of p38LZ shares sequence homology with GCN4LZ. In each heptad repeat, the a and d positions are indicated. B: Helical
wheel diagrams of p38LZ and GCN4LZ. The residues are indicated by the one-letter amino acid code and the sequence number.
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p38LZ. The backbone root mean square deviation (rmsd) for
the average structure was 0.51 AS for residues L55^L76. The
p38LZ structure exhibits typical amphipathic characteristics.
One side of the helical region is mainly composed of hydro-
phobic amino acids, while the hydrophilic amino acids are
located on the other side of the helix.
As mentioned previously, p38LZ and GCN4LZ share a
similar sequence. The residues at the a and d positions in
each heptad repeat are mainly occupied by hydrophobic ami-
no acids in both motifs. The exceptions are the presence of
hydrophilic amino acids, Q59 of p38LZ and N264 of
GCN4LZ. Q59 of p38LZ is located at the a position in the
second heptad repeat, while N264 of GCN4LZ is located at
the a position of the third repeat. The di¡erent positioning of
the hydrophilic residues on the hydrophobic side of the am-
phipathic helix seems to be involved in the binding speci¢city
of the leucine zipper-mediated homo- or heterodimerization.
3.5. In vitro binding of p38LZ with other components of the
ARS complex
Previous studies using the yeast two-hybrid method and the
deletion mutants of p38 revealed that p38 binds to p43, RRS,
and QRS [13,18] and that the amino acids 1^83 of p38 are
responsible for the binding to p43 [18]. In our experiments,
Fig. 3. Overview of the NOE connectivities, coupling constants, and amide proton exchange rates of p38LZ in the 50% TFE/water solution.
The thickness of the bar re£ects the NOE intensities, which are classi¢ed into three groups. The small (6 6 Hz) coupling constants are repre-
sented as ¢lled circles. The exchange rates of the amide protons are represented as black (slow), gray (moderate), and white (fast) circles.
Fig. 4. Solution structure of p38LZ. A: Superimposition of the ensemble of the ¢nal 20 simulated annealing structures of p38LZ. B: The cen-
tral region (L55^L76) of the amphipathic helix, with the side chains at the a and d positions in each heptad repeat shown. Hydrophobic amino
acids are found along one side of the helix. C: Ribbon representation of the average structure of p38LZ. The images were generated by Midas-
Plus [36].
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the in vitro binding of p38LZ with other components of the
multi-ARS complex was examined. The p43 protein and the
hydrophobic polypeptide appendices of RRS and QRS were
selected to test the binding to p38LZ, since these appendices
were suggested to be the interfaces of the protein^protein
interaction [7^9]. As shown in Fig. 5, p43 could bind to
p38LZ, while RRS-N172 and QRS-N1236 could not. To
identify the p38LZ binding site of p43, we separately ex-
pressed the N-terminal and C-terminal domains of p43 and
examined their binding to p38LZ. The leucine zipper motif of
p38 was found to bind to the N-terminal domain of p43.
Although we could not quantitatively characterize the bind-
ing between p38LZ and p43, the binding seems to be a speci¢c
interaction. The in vitro binding of p38LZ to p43 was per-
formed in the presence of the high NaCl concentration
(500 mM). Thus, this binding is likely to be strong and spe-
ci¢c, which is consistent with the previous result that the bind-
ing between p38 and p43 is a strong interaction.
The prediction of coiled-coil motifs by the programs COIL
[30] and Paircoil [31] indicated that not only p38, but also
p43, RRS, and QRS have a potential coiled-coil motif in their
N-terminal domains (Fig. 6). These predicted coiled-coil mo-
tifs consist of about 30 amino acids, and p43 and RRS were
found to have two coiled-coil motifs in their N-terminal do-
mains. However, the in vitro binding experiments showed that
only the N-terminal domain of p43 could bind to p38LZ. It
has been suggested that discrete interaction sites exist on p38
for each of its interacting partners [13,17], and that there is no
competitive binding to p38 between other components [17].
Thus, the binding of p38 to p43 would be responsible for
the speci¢c interaction in the coiled-coil manner between the
leucine zipper motif of p38 and one coiled-coil motif of p43.
3.6. Implications of the protein^protein interactions
Coiled-coil motifs have been shown to be important for
mediating protein oligomerization [32]. These motifs share a
characteristic seven-amino acid repeat, (abcdefg)n, with hydro-
phobic residues at the a and d positions and polar residues
generally elsewhere [33^35]. The coiled-coil sequences with
this heptad repeat pattern can adopt homo- or heterodimeric
conformations. A leucine zipper dimerization domain from
the yeast transcription factor GCN4 forms a parallel, dimeric
coiled-coil [27]. The p38 protein is known to form a homo-
dimer; however, the dimerization of p38 was shown to occur
via the interaction of its C-terminal domain [13]. In this work,
the putative leucine zipper motif of p38 showed no evidence of
homodimerization in the NMR spectrum and in the ultracen-
trifugation experiments.
The p38 and p43 proteins are located in the central region
of the multi-ARS complex [17,18], and can each bind to sev-
eral ARSs. Previous studies have indicated that the binding of
p38 to p43, DRS or KRS is a strong interaction, and that of
p38 to RRS or QRS is weaker [17]. The reconstitution of the
sub-complex containing p38, p43, QRS, and RRS revealed
that synergistic e¡ects for the association of the weakly inter-
acting proteins are involved in the formation of the macro-
molecular assembly, and that the formation of the p38^p43
complex is a prerequisite for the subsequent assembly of RRS
and QRS [17]. On the basis of deletion analyses of p38 and
other previous work, the components of the complex have
been grouped into two sub-complexes by their association
with p38 [18]. One sub-complex consists of p43, RRS, and
QRS anchored to the N-terminal domain of p38. The other
sub-complex appeared to be directly or indirectly associated
with the C-terminal 236-aa peptide of p38. Based upon our
¢ndings, we propose that the association of p38 and p43
should be attributed to the speci¢c coiled-coil interaction. An-
other coiled-coil interaction is likely to be involved in the
protein^protein interaction for the assembly of the multi-
ARS complex. The N-terminal domain of RRS was found
to bind to the N-terminal domain of p43, where the coiled-
coil motifs in RRS and p43 suggested the strong possibility of
the involvement of a coiled-coil interaction between the
N-terminal domains of the two proteins. Thus, the presence
of the coiled-coil motifs in various components of the complex
suggests that the coiled-coil-mediated, speci¢c protein^protein
interactions are largely involved in the self-association or het-
ero-oligomerization of the components. These protein^protein
interactions between p38, p43, RRS, and QRS would stabilize
the complex and contribute to the completion of the assembly
of the multi-ARS complex.
4. Concluding remark
A leucine zipper-like motif in p38 was identi¢ed, and the
Fig. 5. In vitro binding of p38LZ to other components of the multi-
ARS complex. The binding of proteins to p38LZ was con¢rmed by
co-puri¢cation of the complex, which was detected by Tris-Tricine
SDS^PAGE. Lane 1: molecular weight markers; lane 2: p38LZ-
bound p43; lane 3: N-terminal domain of p43. The C-terminal do-
main of p43 (lane 4), and the N-terminal domains of QRS (lane 5)
and RRS (lane 6) could not bind to p38LZ. Lane 7: free p38LZ.
Molecular weights are indicated on the left of the ¢gure, and the
proteins and peptides are indicated on the right of the ¢gure.
Fig. 6. Prediction of the presence of a coiled-coil motif. The predic-
tion of a coiled-coil motif was performed using the COIL [30] and
Paircoil [31] programs. The threshold score of the prediction was
0.5 for both programs. The predicted coiled-coil motifs from both
the COIL and Paircoil programs are indicated by black boxes with
the residue numbers, and the motifs predicted only by the COIL
program are indicated by gray boxes with the residue numbers.
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solution structure of this motif was investigated by CD and
NMR spectroscopy. The leucine zipper motif of p38 was
found to be a single amphipathic K-helix, and its structure
was expected to resemble the intact structure in p38. The
binding of p38 to p43 was investigated in vitro. The associa-
tion between p38 and p43 would be formed through the in-
teraction between the leucine zipper-like motif of p38 and the
N-terminal domain of p43, and this interaction might occur in
a speci¢c coiled-coil manner. The p38^p43 complex is capable
of binding with other ARSs to form a multi-ARS complex.
Thus, the coiled-coil-mediated p38^p43 complex would pro-
vide the sca¡old of the protein^protein interactions to stabi-
lize the complex and facilitate macromolecular assembly.
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